BMS AI444046 A Long Term Followup Study of Subjects Who Participated in a Clinical Trial in Which Asunaprevir (BMS650032) and/or Daclatasvir (BMS790052) was Administered for the treatment of Chroinic Hepatitis C.
Investigator: Dushyantha T. Jayaweera
Institutional Protocol #: 20130476
National Clinical Trials Identifier: NCT01492504
Division: Infectious Diseases
Therapeutic Area: Infectious Diseases
Phase: Phase III
Enrolling Since: 9/18/2013